دورية أكاديمية

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

التفاصيل البيبلوغرافية
العنوان: Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
المؤلفون: Egelston, Colt A., Guo, Weihua, Yost, Susan E., Ge, Xuan, Lee, Jin Sun, Frankel, Paul H., Cui, Yujie, Ruel, Christopher, Schmolze, Daniel, Murga, Mireya, Tang, Aileen, Martinez, Norma, Karimi, Misagh, Somlo, George, Lee, Peter P., Waisman, James R., Yuan, YuanAff2, Aff5, IDs0026202303470y_cor17
المصدر: Cancer Immunology, Immunotherapy. 72(9):3013-3027
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:03407004
14320851
DOI:10.1007/s00262-023-03470-y